Five classic risk factors for cardiovascular disease — high blood pressure, high cholesterol, obesity, diabetes, and smoking — at age 50 can reduce life expectancy by more than 10 years. This is the conclusion of an international study led by German researchers and presented at the 2025 American College of Cardiology Scientific Session. “These five … Read more
Individuals testing positive for human papillomavirus (HPV) had a 40% greater risk for overall cardiovascular disease (CVD) than HPV-negative individuals, based on the data from nearly 250,000 patients. The findings were presented at the American College of Cardiology Annual Scientific Session and Expo. “Although high-risk HPV is known to play a role in anogenital cancers, … Read more
Point-of-care (POC) testing can significantly increase routine lipid screening of preteen patients, according to findings from a study published in Pediatrics. At the beginning of the study, testing rates at three pediatric primary care sites in Pennsylvania were between 1% and 10% among preteens aged between 9 and 11 years, despite recommendations from the American … Read more
Higher, long-term butter consumption is linked with increased total and cancer mortality, whereas plant-based oils may offer protective benefits, according to a prospective study of more than 200,000 adults. These findings suggest that choosing plant-based oils over butter could help prevent premature deaths, lead author Yu Zhang, MBBS, of the Harvard T.H. Chan School of … Read more
Almost half of people who experience sudden cardiac death were never diagnosed with cardiovascular disease (CVD) before it was too late, warned investigators. “A substantial number of deaths happen in people we don’t see in the cardiac ward,” said Tobias Skjelbred, MD, a cardiologist at Copenhagen University Hospital and lead author of a new nationwide … Read more
Tirzepatide Shows Promise in Reducing cardiovascular Risk for Obese heart Failure Patients A new analysis of the SUMMIT trial reveals that the glucagon-like peptide 1 (GLP-1) agonist tirzepatide significantly lowers the risk of cardiovascular (CV) events in patients with obesity and heart failure with preserved ejection fraction (HFpEF). This benefit remains consistent nonetheless of whether … Read more
The glucagon-like peptide 1 (GLP-1) agonist tirzepatide lowers the risk for cardiovascular (CV) events in patients with obesity and heart failure with preserved ejection fraction (HFpEF), whether they have general adiposity, measured with the body mass index (BMI), or central adiposity, measured with the waist-to-height ratio, showed a new analysis from the SUMMIT trial. This … Read more
People who ate more plant-based and less meat-based foods — whether on a vegan, vegetarian, or omnivorous diet — had more favorable microbiome compositions than those who did not follow a healthy dietary pattern, new research suggested. For example, red meat was a strong driver of omnivore microbiomes, with corresponding signature microbes that are negatively … Read more